In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Neste reduces focus on renewable chemicals
In Finland, oil company Neste has announced a performance improvement program that includes deemphasizing renewable chemicals. The company cites a significantly changed market environment...
LSU team envisions Fat Tuesday without the waste
In Baton Rouge, a team at Louisiana State University is hoping to scale production of biodegradable, seed-infused Mardi Gras beads to make the state’s...
Edelrid introduces castor oil-based climbing rope
In Germany, mountaineering equipment firm Edelrid has introduced climbing rope made from castor oil.
Birdlime 1R 9.8 climbing rope uses polyamide-11 made from castor oil...